Feb 092011
 

On Monday, February 7, 2011 Health and Human Services Secretary Kathleen Sebelius provided an update on the Community Living Assistance Services and Supports (CLASS) program, created under the Affordable Care Act. The CLASS Act establishes a voluntary insurance program for people who are unable to perform two or more “functional activities of daily living,” such as the ability to feed or dress one’s self without assistance. Unfortunately, such impairments typically accompany the progression of Alzheimer’s […]

Jan 052011
 
Alzheimer's Disease: 2010 Year In Review

In this final blog of the year, we would like to review some of the highlights of what has happened in the AD world, and the new directions that we will likely be heading into in 2011. This year Medivation’s Dimebon, which started life as a Russian antihistamine and showed some promise against Alzheimer’s, failed in its first late-stage clinical trial. Later in the year, Eli Lilly halted development of semagacestat after the compound actually […]

Nov 172010
 

Readers, The Annual Society for Neuroscience Meeting is where fundamental neuroscience research is presented to a worldwide audience. This year’s meeting includes research presentations from many of the cutting edge labs working on AD. In today’s blog, I will summarize a few of the many findings presented at this meeting that are helping us get a better picture of AD, as well as potential new avenues for its treatment. Our current thinking about the cause […]

Jul 142010
 

Early detection, diagnosis and care management for people newly diagnosed with cognitive impairment and dementia reduces outpatient costs by almost 30 percent, according to new research reported today at the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 (AAICAD 2010) in Honolulu. Dementia is loss of memory and other mental abilities severe enough to interfere with daily life. According to the Alzheimer’s Association, dementia is a common, costly, and often unrecognized problem in older adults. […]

Jul 142010
 

-New Alzheimer’s Risk Gene May Affect Memory Scores and Brain Atrophy in Middle Age-Clinical Trial of Intranasal Insulin Shows Benefits in Alzheimer’s and MCI-Known Alzheimer’s Risk Gene May Change Shape of Brain Deposits Last minute scientific submissions to the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 (AAICAD 2010) in Honolulu, HI, known as “hot topics,” suggest that (1) a newly-discovered risk gene for Alzheimer’s may have early impact on memory skills and brain volume, […]

Jul 132010
 

Two Target Tau; Two May Reduce Tau Though Their Target Was Amyloid The primary therapeutic target in Alzheimer’s disease has been the beta amyloid peptide, which clusters outside cells in the brain to form sticky clumps known as plaques. Recently, more attention has been given to the tau protein, which aggregates inside the brain cells of people with Alzheimer’s, forming neurofibrillary tangles. Precisely how these proteins interact in causing the disease is unclear. Four new […]

Jul 132010
 

- Great need for culturally-appropriate Alzheimer care resources & home-based services – Racially and ethnically diverse older adults are one of the fastest growing population segments in the United States and new research presented today at the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 (AAICAD 2010) in Honolulu reveals that older African-Americans and Latinos with significant cognitive impairment have a lower likelihood of nursing home placement and longer survival than White older adults in […]

Jul 122010
 

The Alzheimer’s Association announced today the launch of Alzheimer’s Association TrialMatch™, a confidential and free interactive tool that provides comprehensive clinical trial information and an individualized trial matching service for people with Alzheimer’s disease and related dementias. The Internet (www.alz.org/trialmatch) and phone-based (800-272-3900) service debuted during the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 (AAICAD 2010) in Honolulu, HI. There are as many as 5.3 million Americans living with the Alzheimer’s and every 70 […]

Jul 122010
 

A new website showcasing the latest in Alzheimer’s disease research and science – www.alz.org/research – is being unveiled at the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 (AAICAD 2010) in Honolulu. The website, called the Alzheimer’s Association “Research Center,” presents an extensive portfolio of information designed for a public searching for more knowledge about the current state of Alzheimer research, including both the latest news from the global research effort and how to volunteer […]

Jul 112010
 

Honolulu, Hawaii; July 11, 2010 – The Alzheimer’s Association recognized four scientists for their extraordinary achievements in advancing Alzheimer research at the Alzheimer’s Association International Conference on Alzheimer’s Disease 2010 (AAICAD 2010) in Honolulu, Hawaii. Honorees for their professional and scientific contributions to Alzheimer research are:•Takeshi Iwatsubo, MD, Department of Neuropathology, Graduate School of Medicine at the University of Tokyo.•Karen H. Ashe, MD, PhD, Department of Neurology and Neuroscience Director at the University of Minnesota.•Marsel […]

Alz.org main site  |  Research  |  Advocacy  |  Care and support  |  Message boards  |  Disclaimer  |  Donate  |  Contact us  |  Sign up for e-news
© 2011 Alzheimer's Association | Blog Suffusion theme by Sayontan Sinha